State Street’s Lunai Bioworks LNAI Stock Holding History

State Street’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123K	Buy	37,537 +33,071	+741%	+$91K	﹤0.01%	4014
2026 Q1	$14.6K	Hold	4,466	–	–	﹤0.01%	4233
2025 Q4	$31.5K	Hold	4,466	–	–	﹤0.01%	4207
2025 Q3	$50.7K	Hold	4,466	–	–	﹤0.01%	4155
2025 Q2	$103K	Sell	4,466 -20,574	-82%	-$574K	﹤0.01%	3969
2025 Q1	$1.09M	Sell	25,040 -771	-3%	-$49.3K	﹤0.01%	3409
2024 Q4	$1.73M	Buy	25,811 +9,263	+56%	+$615K	﹤0.01%	3366
2024 Q3	$640K	Buy	16,548 +602	+4%	+$41.7K	﹤0.01%	3549
2024 Q2	$2.23M	Buy	15,946 +14,725	+1,206%	+$2.01M	﹤0.01%	3285
2024 Q1	$259K	Hold	1,221	–	–	﹤0.01%	3816
2023 Q4	$310K	Buy	1,221 +429	+54%	+$118K	﹤0.01%	3772
2023 Q3	$283K	Buy	792 +141	+22%	+$21.4K	﹤0.01%	3836
2023 Q2	$29.5K	Sell	651 -3,192	-83%	-$245K	﹤0.01%	4533
2023 Q1	$281K	Buy	3,843 +23	+0.6%	+$2.02K	﹤0.01%	3949
2022 Q4	$315K	Sell	3,820 -134	-3%	-$18K	﹤0.01%	3932
2022 Q3	$573K	Sell	3,954 -2	-0.1%	-$365	﹤0.01%	3730
2022 Q2	$611K	Buy	3,956 +3,305	+508%	+$1.51M	﹤0.01%	3761
2022 Q1	$430K	Buy	651 +47	+8%	+$25K	﹤0.01%	4114
2021 Q4	$352K	Hold	604	–	–	﹤0.01%	4131
2021 Q3	$325K	Buy	604 +194	+47%	+$94.8K	﹤0.01%	4152
2021 Q2	$163K	Sell	410 -1,942	-83%	-$633K	﹤0.01%	4262
2021 Q1	$666K	Buy	2,352 +4	+0.2%	+$1.18K	﹤0.01%	3698
2020 Q4	$554K	Sell	2,348 -59	-2%	-$14.9K	﹤0.01%	3632
2020 Q3	$689K	Buy	2,407 +476	+25%	+$150K	﹤0.01%	3521
2020 Q2	$651K	Buy	1,931 +396	+26%	+$119K	﹤0.01%	3504
2020 Q1	$368K	Buy	1,535 +767	+100%	+$228K	﹤0.01%	3500
2019 Q4	$308K	Buy	768 +370	+93%	+$163K	﹤0.01%	3581
2019 Q3	$175K	Sell	398 -8	-2%	-$3.06K	﹤0.01%	3621
2019 Q2	$106K	Buy	+406	New	+$198K	﹤0.01%	3668

Other funds holding LNAI

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

State Street's LNAI Position: Q2 2026 in Review

State Street increased its Lunai Bioworks (LNAI) stake by 741% in Q2 2026, buying an estimated $91K and bringing the position to 37,537 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #4014.

State Street first reported a position in LNAI in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.23M in Q2 2024. 16 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

State Street held 37,537 shares of Lunai Bioworks worth $123K as of Q2 2026.
State Street bought 33,071 Lunai Bioworks shares in Q2 2026, an estimated $91K.
Lunai Bioworks made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4014 holding.
State Street first reported a position in Lunai Bioworks in Q2 2019 and has held it in 29 quarters since.
State Street's Lunai Bioworks position peaked at $2.23M in Q2 2024.
16 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.